Skip to main content

Amphastar Pharma(AMPH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low27.46
Day High28.66
Open:27.46
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
ACCESSWIRE - Fri Sep 2, 1:00AM CDT
ACCESSWIRE
Fri Sep 2, 1:00AM CDT
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jacob Liawatidewi, Executive V.P. of Corporate Administration Center and Sales and Marketing and Tony Marrs Sr. Vice...
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes
ACCESSWIRE - Tue Aug 16, 1:00AM CDT
ACCESSWIRE
Tue Aug 16, 1:00AM CDT
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 16, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's New Drug Application ("NDA") for Epinephrine injection USP,...
Amphastar Pharmaceuticals (AMPH) Q2 2022 Earnings Call Transcript
Motley Fool - Mon Aug 8, 8:30PM CDT
Motley Fool
Mon Aug 8, 8:30PM CDT
AMPH earnings call for the period ending June 30, 2022.

Latest Articles

Initial public offerings scheduled to debut next week